• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926008220
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/13/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device is a combination product.(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgment occurred.The target lesion was located in the tortuous coronary artery in which a stent had been previously implanted.A 2.25 x 8mm synergy ii stent was advanced for to treat the lesion and the stent slipped off from the balloon.Another balloon catheter was advanced and the dislodged stent was expanded properly to complete the procedure.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device avail.For eval, returned to mfr.On, device returned to mfr., device evaluated by mfr., eval summary attached, method codes, result codes, conclusion codes updated.Device evaluated by mfr: synergy ii us mr 2.25 x 8mm stent delivery system (sds) was returned for analysis with the stent detached from the device.No stent returned.Stent separated from sds.The balloon was reviewed.There was no stent on the balloon.The balloon folds were present but were slightly relaxed from their folded position.Crimp markings were evident on the exposed balloon wall, indicating correct positioning and crimping of the stent prior to the event.A visual and tactile examination of the hypotube found multiple hypotube kinks.A visual and tactile examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.A visual and microscopic examination of the tip found no damage.No other issues were identified during analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is operational context as the product meets the design & manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.Bsc id# (b)(6).Tw# (b)(4).
 
Event or Problem Description
It was reported that stent dislodgment occurred.The target lesion was located in the tortuous coronary artery in which a stent had been previously implanted.A 2.25 x 8mm synergy ii stent was advanced for to treat the lesion and the stent slipped off from the balloon.Another balloon catheter was advanced and the dislodged stent was expanded properly to complete the procedure.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7327700
Report Number2134265-2018-01667
Device Sequence Number13817024
Product Code NIQ
UDI-Device Identifier08714729839965
UDI-Public08714729839965
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/21/2018
Device Model NumberH7493926008220
Device Catalogue Number39260-0822
Device Lot Number0021063553
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2018
Initial Date Received by Manufacturer 02/14/2018
Supplement Date Received by Manufacturer10/02/2018
Initial Report FDA Received Date03/09/2018
Supplement Report FDA Received Date10/17/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
-
-